Professional Documents
Culture Documents
31 MAR MAR2014: Weekly Stock Weekly Stock Analysis
31 MAR MAR2014: Weekly Stock Weekly Stock Analysis
MARKET WRAP
The broader Nifty rose as much as 0.91% to an all-time high of 6,702.6, while the benchmark gained 0.67% to a lifetime high of 22,363.97. Indian equity market rose to record highs for a fifth straight session on Friday as state-run lenders including State Bank of India extended recent gains after RBI extended the deadline for banks to implement Basel III rules by a year.
LAST WEEK PERFORMANCE-
2 callls hit targets we had given last week, in which SSLT hit 1st target & made high 185.80(buy call given@176.45),AURO PHARMA hit 1st target & made low543(buy call given@536), CROMP GREAVE hit 1st target & made low150(sell call given@154).
PRICE
121.20
STOCK RECOMMENDATION
BUY BUY BUY SELL SELL
183.80
516 162.90 163.75
KTK BANK
S2 110
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING BUY SIGNAL IN KTK BANK SO TRADER CAN BUY KTK BANK AT 121.20 FOR TG-124/127 124/127
SSLT
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING BUY SIGNAL IN SSLT SO TRADER CAN BUY SSLT AT 183.80 FOR TG-188/195
AURO PHARMA
S2 480
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING BUY SIGNAL IN AURO PHARMA SO TRADER CAN BUY AURO PHARMA AT 516 FOR TG-524/535 524/535
VOLTAS
S2 150
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING SELL SIGNAL IN VOLTAS SO TRADER CAN SELL VOLTAS AT 162.90 FOR TG-160/156
CROMPGREAVES
S1 140
S2 125
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING SELL SIGNAL IN CROMPGREAVES SO TRADER CAN SELL CROMPGREAVES AT 163.75 FOR TG-161/157
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein CAN be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. TheEquicom recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. TheEquicom shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to TheEquicom might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in Commodity and equity market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above. TheEquicom does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.